Agah Ramtin — SEC insider filings

SEC reporting owner CIK 1862617. 23 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2021-10-04 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
RenovoRx, Inc. (RNXT)Executive Chairman and CMO, Director2315 legs · 272,165 sh · $217,593—15

Insider filings — Agah Ramtin

FiledFormIssuerReported transactionsSource
2026-11-174RenovoRx, Inc. (RNXT)Purchase (P): 50,000 @ $0.93EDGAR
2026-04-074RenovoRx, Inc. (RNXT)Grant/award (A): 621,727 (derivative) @ $0EDGAR
2026-01-224RenovoRx, Inc. (RNXT)Purchase (P): 10,000 @ $1.00EDGAR
2026-01-054RenovoRx, Inc. (RNXT)Purchase (P): 9,795 @ $0.86EDGAR
2026-01-024RenovoRx, Inc. (RNXT)Purchase (P): 205 @ $0.83EDGAR
2025-12-174RenovoRx, Inc. (RNXT)Purchase (P): 12,000 @ $0.85EDGAR
2025-12-084RenovoRx, Inc. (RNXT)Purchase (P): 10,000 @ $0.96EDGAR
2025-11-244RenovoRx, Inc. (RNXT)Purchase (P): 10,000 @ $0.80 · Purchase (P): 12,000 @ $0.80EDGAR
2025-07-034RenovoRx, Inc. (RNXT)Grant/award (A): 63,636 (derivative) @ $0EDGAR
2025-06-094RenovoRx, Inc. (RNXT)Purchase (P): 21,000 @ $1.40EDGAR
2025-06-064RenovoRx, Inc. (RNXT)Gift (G): 400,000 @ $0EDGAR
2025-04-174RenovoRx, Inc. (RNXT)Purchase (P): 15,000 @ $0.90EDGAR
2025-04-164RenovoRx, Inc. (RNXT)Grant/award (A): 254,542 (derivative) @ $0EDGAR
2025-04-144RenovoRx, Inc. (RNXT)Purchase (P): 20,000 @ $0.80EDGAR
2025-04-104RenovoRx, Inc. (RNXT)Purchase (P): 30,000 @ $0.81EDGAR
2025-04-094RenovoRx, Inc. (RNXT)Purchase (P): 26,000 @ $0.84EDGAR
2024-01-304RenovoRx, Inc. (RNXT)Purchase (P): 40,983 · Purchase (P): 40,983 (derivative)EDGAR
2024-01-234RenovoRx, Inc. (RNXT)Grant/award (A): 28,424 (derivative) @ $0 · Grant/award (A): 125,132 (derivative) @ $0EDGAR
2023-03-294RenovoRx, Inc. (RNXT)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2022-06-174RenovoRx, Inc. (RNXT)Conversion (C): 1,295 · Conversion (C): 1,295 (derivative) @ $0 · Conversion (C): 1,295 (derivative) @ $0EDGAR
2022-06-094RenovoRx, Inc. (RNXT)Gift (G): 975,000 @ $0 · Gift (G): 975,000 @ $0 · Purchase (P): 5,182 @ $1.93EDGAR
2022-03-144RenovoRx, Inc. (RNXT)Grant/award (A): 21,398 (derivative) @ $0EDGAR
2021-10-044RenovoRx, Inc. (RNXT)Grant/award (A): 52,203 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1862617 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs